Physician profile
Amer Ansari
NPI 1295996106
$1,487.05
in general payments reported to CMS, 2019-2025
12 companies · $588 in 2025
The $588 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.49 · 2020: $78.89 · 2021: $95.79 · 2022: $109 · 2023: $113 · 2024: $488 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,169 · Education: $20.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,168.50 |
| Education | $20.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $940.48 | 2019-2025 | Wavewriter Alpha Prime 16, Infinion 16, General - Therapies |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $131.94 | 2021-2025 | Relistor |
| Curonix LLC | $91.74 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $57.05 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Horizon Therapeutics Plc | $55.64 | 2020-2021 | |
| Pfizer INC. | $39.97 | 2025 | |
| Globus Medical, INC. | $38.48 | 2025 | Senza |
| Nevro Corp. | $37.52 | 2020-2024 | Senza |
| Spinal Simplicity, LLC | $32.21 | 2024 | Ha Minuteman G3-R |
| Biodelivery Sciences International, INC. | $30.10 | 2020 | |
| Scilex Pharmaceuticals INC. | $17.35 | 2022 | |
| Abbott Laboratories | $14.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amer Ansari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.